0001104659-17-047846.txt : 20170728
0001104659-17-047846.hdr.sgml : 20170728
20170728190051
ACCESSION NUMBER: 0001104659-17-047846
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170728
FILED AS OF DATE: 20170728
DATE AS OF CHANGE: 20170728
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Charles Scott J
CENTRAL INDEX KEY: 0001649483
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37691
FILM NUMBER: 17991229
MAIL ADDRESS:
STREET 1: 1414 RALEIGH ROAD, SUITE 400
STREET 2: SUITE 400
CITY: CHAPEL HILL
STATE: NC
ZIP: 27517
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aralez Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001660719
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101
CITY: MISSISSAUGA
STATE: A6
ZIP: L5N 0E4
BUSINESS PHONE: 905-876-1118
MAIL ADDRESS:
STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101
CITY: MISSISSAUGA
STATE: A6
ZIP: L5N 0E4
4
1
a4.xml
4
X0306
4
2017-07-28
0
0001660719
Aralez Pharmaceuticals Inc.
ARLZ
0001649483
Charles Scott J
C/O ARALEZ PHARMACEUTICALS INC.,
7100 WEST CREDIT AVENUE, SUITE 101
MISSISSAUGA
A6
L5N 0E4
ONTARIO, CANADA
0
1
0
0
Chief Financial Officer
Common Shares, without par value
2017-07-28
4
S
0
10804
1.2504
D
280551
D
This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 29,000 restricted stock units, which vested on July 27, 2017. 7,284 of such restricted stock units were previously granted on July 27, 2015 and 21,716 of such restricted stock units were previously granted on February 12, 2016.
/s/ Eric L. Trachtenberg, attorney-in-fact for Scott J. Charles
2017-07-28